Rotterdam Criteria–Based Diagnostic Subtype Is Not a Strong Predictor of Cutaneous Phenotype in Patients With Polycystic Ovary Syndrome: A Cross-Sectional Study

    June 2017 in “ Journal of The American Academy of Dermatology ”
    Timothy H. Schmidt, Jean Phillip Okhovat, Keshav Khanijow, Heather G. Huddleston, Marcelle I. Cedars, Lauri A. Pasch, Erica T. Wang, Julie Lee, Kanade Shinkai
    Image of study
    TLDR The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.
    In the 2017 cross-sectional study involving 255 women with polycystic ovary syndrome (PCOS), researchers found that the different PCOS subtypes, as defined by the Rotterdam criteria, did not significantly predict variations in skin manifestations such as hirsutism, acanthosis nigricans, acne, and androgenic alopecia, nor did they predict differences in metabolic phenotypes and cardiometabolic risk profiles. Obesity was identified as a significant factor associated with both metabolic abnormalities and increased skin findings, while the impact of biochemical hyperandrogenism on these phenotypes was less clear. The study concluded that PCOS subtypes are not reliable indicators of cutaneous or metabolic phenotype, suggesting that obesity should be a primary focus in PCOS management, and questioned the classification of the OA + PCO subtype due to its less severe phenotype.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 3 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  53 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community C’est terrible - at my wits end

      in Female  449 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 6 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Similar Research

    5 / 1000+ results